1. Home
  2. EVO vs MG Comparison

EVO vs MG Comparison

Compare EVO & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.53

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Logo Mistras Group Inc

MG

Mistras Group Inc

HOLD

Current Price

$21.26

Market Cap

531.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
MG
Founded
1993
1978
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
568.6M
531.0M
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
EVO
MG
Price
$1.53
$21.26
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $4.23
N/A
AVG Volume (30 Days)
83.4K
★ 271.9K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.30
Revenue
N/A
★ $700,970,000.00
Revenue This Year
N/A
$3.18
Revenue Next Year
$20.47
$5.37
P/E Ratio
★ N/A
$71.90
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$9.45
52 Week High
$4.19
$21.92

Technical Indicators

Market Signals
Indicator
EVO
MG
Relative Strength Index (RSI) 45.54 57.56
Support Level $1.50 $20.36
Resistance Level $1.97 $21.85
Average True Range (ATR) 0.05 0.38
MACD 0.02 -0.03
Stochastic Oscillator 60.73 53.57

Price Performance

Historical Comparison
EVO
MG

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

Share on Social Networks: